Drug Type Small molecule drug |
Synonyms KQ 791, KQ791 |
Target |
Action inhibitors |
Mechanism PTP1B inhibitors(Protein-tyrosine phosphatase 1B inhibitors), Insulin sensitizers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 1 | United States | 01 Jun 2015 | |
| Insulin Resistance | Phase 1 | Canada | 01 Feb 2015 |
Phase 1 | 81 | (KQ-791 Dose 1) | jsykxhepir(srfsbxsiwo) = mydkutxtqc pntevcplfy (ajocpwnmed, 22.99) View more | - | 30 Oct 2019 | ||
(KQ-791 Dose 2) | jsykxhepir(srfsbxsiwo) = msnvjwjwxm pntevcplfy (ajocpwnmed, 30.63) View more |





